SCHEMBL23200233

SCHEMBL23200233

C=C/C=C\C(C)NC(=O)c1cc(C)c2c(n1)CN(C(=O)OC(C)(C)C)CC2

nearest known ligand 0.38

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ PARP1 P09874 1/20 0.38
▸ TNKS2 Q9H2K2 1/20 0.38
▸ PARP2 Q9UGN5 1/20 0.38
▸ MTOR P42345 2/20 0.37
▸ FABP4 P15090 1/20 0.37
▸ FABP5 Q01469 1/20 0.37
▸ GRAMD1A Q96CP6 1/20 0.37
▸ RAF1 P04049 1/20 0.36
▸ BRAF P15056 1/20 0.36
▸ F12 P00748 1/20 0.35
▸ MAP3K5 Q99683 4/20 0.35
▸ ESR2 Q92731 1/20 0.35
▸ NR1H2 P55055 1/20 0.34
▸ C5AR1 P21730 3/20 0.34
▸ MAPT P10636 2/20 0.34
▸ SPR P35270 1/20 0.33
▸ MKNK1 Q9BUB5 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23198474 0.78 PARP1 (0.46) PARP1TNKS2PARP2MTORFABP4
SCHEMBL23199846 0.78 PARP1 (0.47) PARP1TNKS2PARP2MTORFABP4
SCHEMBL23198443 0.74 ADORA1 (0.52) PARP1TNKS2PARP2MTORRAF1
SCHEMBL23202652 0.71 PARP1 (0.43) PARP1TNKS2PARP2MTORRAF1
SCHEMBL23199117 0.68 C5AR1 (0.42) PARP1TNKS2PARP2MTORNR1H2
SCHEMBL23199026 0.68 C5AR1 (0.43) PARP1TNKS2PARP2MTORESR2
SCHEMBL23202660 0.67 ADORA1 (0.48) PARP1TNKS2PARP2MTORFABP4
SCHEMBL31576175 0.67 GPR119 (0.47) PARP1TNKS2PARP2F12ESR2
SCHEMBL23198536 0.66 ADORA1 (0.49) PARP1TNKS2PARP2MTORF12
SCHEMBL15502960 0.66 ESR2 (0.50) PARP1TNKS2PARP2F12ESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021063404-A1 COMPOUND AS SMALL MOLECULE INHIBITOR PD-1/PD-L1 AND APPLICATION THEREOF 南京明德新药研发有限公司 2021-04-08 — — WO disclosed
Send feedback